Boston Common Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,564
| Closed | -$861K | – | 352 |
|
|
2022
Q4 | $861K | Sell |
1,564
-66
| -4% | -$35K | 0.04% | 172 |
|
|
2022
Q3 | $827K | Sell |
1,630
-1
| -0.1% | -$560 | 0.04% | 174 |
|
|
2022
Q2 | $886K | Buy |
1,631
+115
| +8% | +$63.3K | 0.04% | 177 |
|
|
2022
Q1 | $895K | Sell |
1,516
-148
| -9% | -$85K | 0.04% | 174 |
|
|
2021
Q4 | $1.11M | Buy |
1,664
+98
| +6% | +$61.2K | 0.04% | 168 |
|
|
2021
Q3 | $895K | Buy |
1,566
+5
| +0.3% | +$2.74K | 0.04% | 173 |
|
|
2021
Q2 | $787K | Buy |
1,561
+70
| +5% | +$33K | 0.03% | 188 |
|
|
2021
Q1 | $680K | Buy |
1,491
+102
| +7% | +$48.7K | 0.04% | 189 |
|
|
2020
Q4 | $647K | Sell |
1,389
-5,759
| -81% | -$2.7M | 0.05% | 185 |
|
|
2020
Q3 | $3.16M | Sell |
7,148
-2,590
| -27% | -$1.07M | 0.3% | 90 |
|
|
2020
Q2 | $3.53M | Buy |
9,738
+2,745
| +39% | +$920K | 0.38% | 78 |
|
|
2020
Q1 | $1.98M | Buy |
+6,993
| New | +$2.21M | 0.28% | 82 |
|
|
2019
Q3 | – | Sell |
-6,596
| Closed | -$1.94M | – | 192 |
|
|
2019
Q2 | $1.94M | Sell |
6,596
-765
| -10% | -$211K | 0.24% | 88 |
|
|
2019
Q1 | $2.02M | Sell |
7,361
-207
| -3% | -$51.5K | 0.26% | 90 |
|
|
2018
Q4 | $1.69M | Sell |
7,568
-55
| -0.7% | -$12.9K | 0.25% | 93 |
|
|
2018
Q3 | $1.86M | Buy |
7,623
+635
| +9% | +$146K | 0.23% | 94 |
|
|
2018
Q2 | $1.45M | Buy |
6,988
+1,465
| +27% | +$311K | 0.18% | 97 |
|
|
2018
Q1 | $1.14M | Sell |
5,523
-611
| -10% | -$128K | 0.13% | 122 |
|
|
2017
Q4 | $1.17M | Sell |
6,134
-530
| -8% | -$102K | 0.14% | 116 |
|
|
2017
Q3 | $1.26M | Buy |
6,664
+25
| +0.4% | +$4.53K | 0.16% | 104 |
|
|
2017
Q2 | $1.16M | Buy |
6,639
+770
| +13% | +$129K | 0.15% | 109 |
|
|
2017
Q1 | $901K | Sell |
5,869
-26
| -0.4% | -$3.97K | 0.12% | 124 |
|
|
2016
Q4 | $832K | Buy |
5,895
+75
| +1% | +$11.1K | 0.12% | 125 |
|
|
2016
Q3 | $926K | Sell |
5,820
-110
| -2% | -$16.9K | 0.05% | 199 |
|
|
2016
Q2 | $876K | Sell |
5,930
-1,970
| -25% | -$291K | 0.05% | 193 |
|
|
2016
Q1 | $1.12M | Buy |
7,900
+20
| +0.3% | +$2.68K | 0.06% | 181 |
|
|
2015
Q4 | $1.12M | Hold |
7,880
| – | – | 0.06% | 181 |
|
|
2015
Q3 | $964K | Buy |
7,880
+3,345
| +74% | +$436K | 0.06% | 186 |
|
|
2015
Q2 | $588K | Sell |
4,535
-110
| -2% | -$14.3K | 0.03% | 226 |
|
|
2015
Q1 | $624K | Sell |
4,645
-200
| -4% | -$25.8K | 0.03% | 226 |
|
|
2014
Q4 | $607K | Sell |
4,845
-15
| -0.3% | -$1.82K | 0.03% | 221 |
|
|
2014
Q3 | $591K | Sell |
4,860
-105
| -2% | -$12.8K | 0.03% | 226 |
|
|
2014
Q2 | $586K | Sell |
4,965
-605
| -11% | -$71.2K | 0.03% | 223 |
|
|
2014
Q1 | $670K | Sell |
5,570
-575
| -9% | -$68.4K | 0.04% | 220 |
|
|
2013
Q4 | $684K | Buy |
6,145
+325
| +6% | +$32.3K | 0.04% | 220 |
|
|
2013
Q3 | $536K | Sell |
5,820
-130
| -2% | -$11.8K | 0.03% | 236 |
|
|
2013
Q2 | $504K | Buy |
+5,950
| New | +$495K | 0.03% | 236 |
|
Other funds holding TMO
Boston Common Asset Management's TMO Position: Q1 2023 in Review
Boston Common Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 1,564 shares — an estimated $861K sold.
Boston Common Asset Management first reported a position in TMO in Q2 2013 and held it in 37 quarters. The position peaked at $3.53M in Q2 2020. 2,386 funds tracked by Wall St. Rank hold TMO as of Q1 2023.
- Boston Common Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
- Boston Common Asset Management sold 1,564 Thermo Fisher Scientific shares in Q1 2023, an estimated $861K.
- Boston Common Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 37 quarters.
- Boston Common Asset Management's Thermo Fisher Scientific position peaked at $3.53M in Q2 2020.
- 2,386 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.
Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.